@BiomedicalRX Avatar @BiomedicalRX BioMedicalRx ๐Ÿงฌ ๐Ÿ‡บ๐Ÿ‡ธ โœ๏ธ

BioMedicalRx ๐Ÿงฌ ๐Ÿ‡บ๐Ÿ‡ธ โœ๏ธ posts on X about $ipsc, $arwr, $xbi, $prme the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 71.03% finance 17.76% cryptocurrencies 5.61% vc firms 3.74% countries 3.74% financial services 1.87% celebrities 1.87% technology brands 0.93%

Social topic influence $ipsc #1, $arwr 12.15%, $xbi 12.15%, $prme #45, $crbu 9.35%, $crsp 8.41%, $sana #5, $fate #1, $arkg 6.54%, $xers 5.61%

Top accounts mentioned or mentioned by @yaireinhorn @jessiechimni @steve2bacon @arrowheadpharma @pfizer @dadbod4evah @kholov23 @ny197247 @cariboubio @elonmusk @bambossie81 @davidwainer @cariboubios @tricoloredeel @biotechxguru @carolynyjohnson @crisprsam @albertbourla @johnevans3 @beamtx

Top assets mentioned Century Therapeutics, Inc. (IPSC) Arrowhead Research Corporation (ARWR) Prime Medicine, Inc. (PRME) Caribou Biosciences, Inc. (CRBU) CRISPR Therapeutics AG (CRSP) Sana Biotechnology, Inc. (SANA) Intellia Therapeutics, Inc (NTLA) BEAM (BEAM) Sarepta Therapeutics, Inc. (SRPT) BridgeBio Pharma, Inc. Common Stock (BBIO) Metagenomi Technologies, LLC (MGX) Verve Therapeutics Inc. (VERV) Kyverna Therapeutics, Inc. (KYTX) ArbitrageCT (ARCT) Eli Lilly and Company (LLY) SPDR S&P [---] ETF Trust (SPY) BlackRock Inc (BLK) Huma Finance (HUMA) Bitcoin (BTC) Alphabet Inc Class A (GOOGL)

Top Social Posts

Top posts by engagements in the last [--] hours

"RT @yaireinhorn: 1/In this great piece - WSJs excellent columnist @david_wainer is shedding light on a very interesting and somewhat predi"
X Link 2026-01-30T16:46Z [----] followers, [--] engagements

"RT @yaireinhorn: This interesting and excellent Natures ๐Ÿ“Š๐Ÿ‘‡shows what were the dominant therapeutic areas in which the FDAs Center for Dru"
X Link 2026-02-08T15:34Z [----] followers, [--] engagements

"RT @yaireinhorn: In my opinion its worth emphasising the deep involvement of @pfizer in @CaribouBios CB-011 ๐Ÿงต๐Ÿ‘‡- which is currently one of"
X Link 2026-02-10T20:01Z [----] followers, [--] engagements

"Not sure I could consistently drink 20g of creatine I would love that cognitive bump though A SINGLE 20g dose of creatine increases cognitive processing speed by 24.5% within [---] hours. A placebo-controlled trial found that creatine rapidly enhanced brain bioenergetics and improved cognitive performance during sleep deprivation with effects lasting up to nine hours. https://t.co/4mjYJcTBI6 A SINGLE 20g dose of creatine increases cognitive processing speed by 24.5% within [---] hours. A placebo-controlled trial found that creatine rapidly enhanced brain bioenergetics and improved cognitive"
X Link 2026-02-12T04:29Z [----] followers, [---] engagements

"$IPSC by my calculation there are now 263.4M shares. Thus actual current MC = [-----] M. That is pretty insane when the MC got as low as [---] M. TCG actually has [--] M shares We will have to see how much some of these massive shareholders sell (the filing simply allows them to sell) https://investors.centurytx.com/static-files/6c19591c-13a8-4adb-a6da-27ac572ab189 https://investors.centurytx.com/static-files/6c19591c-13a8-4adb-a6da-27ac572ab189"
X Link 2026-02-13T03:28Z [----] followers, [----] engagements

"For comparison - $SANa and $FATE FATE is way too cheap. @JessieChimni"
X Link 2026-02-13T03:30Z [----] followers, [----] engagements

"$IPSC likely incorrect above and actually [---] M shares thus MC = [---] M"
X Link 2026-02-13T22:45Z [----] followers, [---] engagements

"$IPSC $FATE $SANA would love to see one of these companies take a stab at Parkinsons disease. Massive TAM and huge unmet need. https://pmc.ncbi.nlm.nih.gov/articles/PMC11881713/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11881713/"
X Link 2026-02-14T04:47Z [----] followers, [---] engagements

"Updated biotech holdings (March 2025) *in order of size No significant changes and size of position based off of appreciation / depreciation of valuations. $XERS - took some profits finally $ARWR $CRSP $BBIO $IPSC $FATE $HUMA $CRBU $AUTL - new used funds from XERS $BEAM $ARCT $KYTX $PRME $MGX - new used funds from XERS hedges are cash $SGOV $TLT $BIL patience use of money I do not need anytime soon. Last [--] hedges are essential in biotech imho Trying to avoid putting new money into biotech due to sentiment and consequent performance. My strategy is basically trying to have a few big successes"
X Link 2025-03-21T22:04Z [----] followers, 18.3K engagements

"Demand continues ๐Ÿคฉ $PRME"
X Link 2025-07-14T19:40Z [----] followers, [----] engagements

"@tricoloredeel @BiotechXGuru @Dadbod4evah I like $CRBU as they approach a phase [--] trial for NHL. I also like how Rachel runs things Like $MGX as a trading vehicle"
X Link 2025-12-23T20:13Z [----] followers, [---] engagements

"My concentrated / conviction biotech companies for [----] $PRME - moderate risk $FATE - mild to moderate risk $ARWR - less risk $IPSC - very high risk $XERS - less risk As normal I plan to trade aggressively around core positions. I do not intend to get myself into another pickle with relentless buying (IPSC) dips anymore. One of these times Ill be forced to eat a large loss (luck runs out). Also not a complete list. Not advice high risk overall. https://twitter.com/i/web/status/2009768815878623458 https://twitter.com/i/web/status/2009768815878623458"
X Link 2026-01-09T23:26Z [----] followers, [----] engagements

"$IPSC over [--] .34 was recent low ๐Ÿ˜ฒ"
X Link 2026-01-12T20:53Z [----] followers, [----] engagements

"$IPSC moving @steve2bacon @kholov23"
X Link 2026-01-13T18:01Z [----] followers, [---] engagements

"Deep Track with 13.4M shares $IPSC BIG https://investors.centurytx.com/static-files/78d1c71b-f67e-4517-9dd4-868dbbcbb5a1 https://investors.centurytx.com/static-files/78d1c71b-f67e-4517-9dd4-868dbbcbb5a1"
X Link 2026-01-16T06:41Z [----] followers, [---] engagements

"$IPSC legit. +Not included due to no recent filings - Versant [----] M Bayer - [----] M Fuji [----] M"
X Link 2026-01-16T06:50Z [----] followers, [----] engagements

"$IPSC boner candle @steve2bacon"
X Link 2026-01-16T20:42Z [----] followers, [----] engagements

"No plans for a reverse share split ๐Ÿ”ฅ $IPSC"
X Link 2026-01-23T22:13Z [----] followers, [----] engagements

"Kudos to the entire c-suite at $IPSC Brent has regained my trust and love the correct direction Century is taking. Now share price will depend on data and execution. What always fascinates me is how sentiment changes with share price. Folks has 6+ months to buy shares around .5 https://twitter.com/i/web/status/2015131546068595148 https://twitter.com/i/web/status/2015131546068595148"
X Link 2026-01-24T18:36Z [----] followers, [----] engagements

"$IPSC Investors [--] months ago vs now -"
X Link 2026-01-25T05:11Z [----] followers, [----] engagements

"$IPSC unrelenting strength ๐Ÿ”ฅ"
X Link 2026-01-27T16:41Z [----] followers, [----] engagements

"$IPSC gap fill we will have to see which way it moves now. Some consolidation would likely be good for the stock"
X Link 2026-01-29T16:35Z [----] followers, [---] engagements

"RT @yaireinhorn: Here is Eli Lillys $LLY CEO Dave Ricks - one of the top-notch CEOs in the Pharma and BioTech ecosystem explaining how th"
X Link 2026-01-30T23:01Z [----] followers, [--] engagements

"@ny1972_47 They are playing with fire imo"
X Link 2026-01-31T17:50Z [----] followers, [---] engagements

"@ny1972_47 Thats the crazy thing with $IPSC s move it wasnt a short squeeze even remotely $FATE has that capability to squeeze"
X Link 2026-01-31T18:45Z [----] followers, [---] engagements

"@steve2bacon silver was up 7% and now flat"
X Link 2026-02-02T03:46Z [----] followers, [---] engagements

"Wonderful content on genetic engineering and its exciting applications for debilitating conditions and conditions where no cures exist. Thank you @yaireinhorn for sharing this article and the nice write up. $BEAM $CRSP $NTLA $XBI 1/In one of the best articles that Ive read recently - Washington Posts excellent science reporter @Carolynyjohnson sheds light on a less known aspect of the Gene Therapy and CRISPR Gene Editing field. Although many Gene Therapies and CRISPR Gene Editing therapies are https://t.co/4e2uLzrpx6 1/In one of the best articles that Ive read recently - Washington Posts"
X Link 2026-02-03T03:15Z [----] followers, [----] engagements

"RT @yaireinhorn: One of the most accurate descriptions of the unbearable situation - in which many Gene Therapies and CRISPR Gene Editing t"
X Link 2026-02-04T15:47Z [----] followers, [--] engagements

"@JessieChimni @CrisprSam ๐Ÿ‘ $CRSP. Sounds very promising"
X Link 2026-02-08T21:00Z [----] followers, [---] engagements

"Been a while. Added $IPSC @ 1.81"
X Link 2026-02-11T20:35Z [----] followers, [---] engagements

"Updated holdings - June [----] ** denotes a concentrated position Commercial $BBIO ** $SRPT $ACRT $CRSP $XERS ** Pre-revenue $ARWR ** $FATE** $BEAM $VERV $NTLA $IPSC ** $KYTX $MGX $ARCT $PRME"
X Link 2025-06-08T17:40Z [----] followers, 10.2K engagements

"$PRME room to run to 5-6 if it can overcome resistance here"
X Link 2026-01-13T05:29Z [----] followers, [----] engagements

"$IPSC more filings done. Ownership now very different ๐Ÿ”ฅ"
X Link 2026-01-16T21:38Z [----] followers, [----] engagements

"Seeing stock futures and cryptocurrencies down nicely the 10-year creeping up and SILVER very green ๐Ÿ‘‡ Lets hope biotech bucks can be contrarian tomorrow ๐Ÿ™ $BTC $XBI $SPY $ARKG"
X Link 2026-02-02T02:53Z [----] followers, [---] engagements

"Very well done $CRBU and strong data imo @CaribouBio ๐Ÿ‘ Thanks for the great write up @yaireinhorn Likey will re-enter here in coming months. Pure cell therapy plays I like for [----] include CRBU $IPSC $FATE 1/๐ŸšจWOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011 CaMMouflage phase [--] clinical trial in cancer patients with relapsed or refractory multiple myeloma (r/r MM). The CB-011 CaMMouflage phase [--] translational and clinical data - which was presented at https://t.co/emfrwEHgux 1/๐ŸšจWOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011"
X Link 2026-02-09T16:30Z [----] followers, [----] engagements

"@yaireinhorn @pfizer @CaribouBio @AlbertBourla That has always been a thought Ive had Would make sense bilaterally"
X Link 2026-02-10T20:01Z [----] followers, [---] engagements

"RT @yaireinhorn: Congrats to @john_evans3 - @beamtx CEO on being a part of the TIME100s Health list which includes the [---] most influent"
X Link 2026-02-14T18:37Z [----] followers, [--] engagements

"Its has surprised me the past few years the apparent visceral hate for $SANA by some. Seriously I wonder why The journalists seem to be rattled while the medical community is thrilled w the exciting initial validation of SANAs technology. Wonderful job SANA"
X Link 2025-01-08T03:32Z [----] followers, [----] engagements

"$ARWR ๐Ÿ‘ ๐Ÿ”ฅ *largest biotech holding ** very exciting upcoming years for @ArrowheadPharma https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-submits-new-drug-application-to-u-s-fda-for-plozasiran-for-the-treatment-of-familial-chylomicronemia-syndrome/ https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-submits-new-drug-application-to-u-s-fda-for-plozasiran-for-the-treatment-of-familial-chylomicronemia-syndrome/"
X Link 2025-01-17T21:47Z [----] followers, [----] engagements

"Admittedly starting to think @GeneInvesting is CORRECT regarding $NTLA. I have small position here that will be increased next week pending no material news / events. Upside downside risk and healthy risk / reward imho. Not advice Damn say what you will about the stock price but the CEO went for blood here. Some of the best soundbites from JPM $NTLA If he buys stock this will exponentially sound 10x better. Some very interesting comments Surprised by his 1/5 and 90% comments for different reasons. https://t.co/pYosfITJcC Damn say what you will about the stock price but the CEO went for blood"
X Link 2025-01-19T01:05Z [----] followers, [----] engagements

"A total of [--] phase I / II / III assets in the clinic for @ArrowheadPharma This is impressive and many ambitious / lucrative targets $ARWR 1/3 https://arrowheadpharma.com/pipeline/ https://arrowheadpharma.com/pipeline/"
X Link 2025-01-20T02:34Z [----] followers, [----] engagements

"Watching filings very closely to see who the relentless seller (s) So far can exclude Blackrock / Syncona. Versant has not filed since last Feb 8th they have over [--] M shares maybe capitulation Bayer Fuji Boxer Casdin and venrock combined = 25M sales watching these closely. $IPSC ๐Ÿ‘‡ https://twitter.com/i/web/status/1887975554495955008 https://twitter.com/i/web/status/1887975554495955008"
X Link 2025-02-07T21:23Z [----] followers, [---] engagements

"Loaded $ARWR at [-----] - minimum will hold these till the tap fills. My largest and most convicted biotech investment"
X Link 2025-02-11T19:04Z [----] followers, [----] engagements

"$XERS With the rest of biotech portfolio struggling and Xeris reaching new multi year highs now by far largest biotech holding. No plans to sell. Likely also a reason Im not living on the street as well ๐Ÿ˜‚ Celebrate wins"
X Link 2025-03-14T21:44Z [----] followers, [----] engagements

"I will give Century Therapeutics credit this is imo easily their best corp presentation they have disseminated. Also FINALLY we are seeing the reason they picked up Clade for [--] M after all was said and done. Call in April to further discuss I will try to be on this call. We are also see Morgan has a very nice command of the finances was able to maintain over [---] M in cash without ATM abuse. The company remains owned by very strong names whom havent capitulated. Bayer Fuji Versant Eli Casdin Venrock Bain Capital etc. Like the focus on autoimmune and pivot in oncology to attack solid tumor."
X Link 2025-03-20T05:27Z [----] followers, [---] engagements

"Updated biotech holdings (April 2025) Active last few weeks $XERS - entire position was sold 5.5-5.9 recently and am slowly buying back in $ARWR - added $CRSP - added $BBIO - sold around [--] and will be buying back Monday $IPSC - very red but holding on adding and may not even at these prices $FATE - most concentrated position and very bullish here. Position tripled over last [--] weeks. $NTLA - too cheap. $HUMA - exited at [--] over 50% loss $CRBU - really like the CEO yet sold position this week (funds moved all to FATE). For tax reasons and more confidence in other cell therapy plays. Likely"
X Link 2025-04-11T21:51Z [----] followers, 15.4K engagements

"$ARWR very exciting program. No way big pharma will not be watching these results. Valuation here remains irresponsible imho. #obesity #diabetes $ARWR ARO-ALK7 https://t.co/d8CWNvEWK3 $ARWR ARO-ALK7 https://t.co/d8CWNvEWK3"
X Link 2025-04-23T01:46Z [----] followers, [----] engagements

"$IPSC Current MC- [--] M Cash and equivalents [---] M and expected to run till Q4 [----]. Burn / Q - 25-32M Century Therapeutics ($IPSC) Preclinical Pipeline Fireside chat: Century Therapeutics ($IPSC) Preclinical Pipeline Fireside Chat This was a very strong review of their pipeline (emphasis on science) and Q&A discussion by Brent (CEO) Chad (CSO) Morgan (CFO) and Greg (CTMO). The most encouraging aspect was that despite the current challenging environment/valuation the team sounded very excited and positive regarding their approach and plan going forward. It is always a pleasure to listen to"
X Link 2025-04-29T05:20Z [----] followers, [----] engagements

"Rest in peace Ollie. You were an absolute wonderful dog and we love you"
X Link 2025-05-03T21:46Z [----] followers, [----] engagements

"Cramer says pass on $ARWR Im raising my targeted price an additional $30. Best news all morning"
X Link 2025-06-04T19:22Z [----] followers, [----] engagements

"Finally finally finally this message (which is true) is gaining traction. $CRSP $PRME $BEAM $XBI $ARKG Sunnier pastures elsewhere shorts. Also never wise to short medicine / therapies that can influence modify and IMPROVE quality of life for many folks .@SecKennedy said yesterday at the FDA: "CRISPR gives the gift of life." He is 100% correct. I appreciate HHS FDA CMS NIH and CBER leadership devoting their morning to communicate their clear support for CRISPR giving such a gift to all of our nation's children who need it. .@SecKennedy said yesterday at the FDA: "CRISPR gives the gift of"
X Link 2025-06-07T04:15Z [----] followers, [----] engagements

"$MSOS @JDVance @elonmusk @VivekGRamaswamy @realDonaldTrump fair question How is cannabis a schedule I but fentanyl that kills millions is schedule ll Something is broken and needs fixing How is cannabis a schedule I but fentanyl that kills millions is schedule ll Something is broken and needs fixing"
X Link 2025-06-10T20:24Z [----] followers, [----] engagements

"$IPSC Perhaps the reason why the Schett/Mackensen group has interest That study should be starting soon - guidance was mid [----] initiation https://investors.centurytx.com/news-releases/news-release-details/century-therapeutics-announces-investigator-initiated-phase-12 $IPSC https://t.co/k9ZVFkP9Jz ๐Ÿ‘ https://t.co/du0uibhsAC https://investors.centurytx.com/news-releases/news-release-details/century-therapeutics-announces-investigator-initiated-phase-12 $IPSC https://t.co/k9ZVFkP9Jz ๐Ÿ‘ https://t.co/du0uibhsAC"
X Link 2025-06-12T05:39Z [----] followers, [----] engagements

"@Biotech2k1 Thats a very good point and underappreciated. Believe it or not that is the reason I still like century therapeutics and I think they will persevere. Greg has had some very nice talks which are worth a listen. Dry but important"
X Link 2025-06-13T22:29Z [----] followers, [---] engagements

"Spectacular data $NTLA ๐Ÿ‘ Market cant really dispute this data. ๐Ÿ’ช Thanks @yaireinhorn for sharing Nice to see good news to contrast the nice 1am PR by $SRPT ๐Ÿคฎ 1/๐ŸšจWOW @intelliatx presented new data from a 3-year follow-up which showed that a single dose of lonvo-z - $NTLA-2002 led to a 98% () reduction in monthly HAE attack rate & all [--] patients were attack-free for a median of [--] months through the latest follow-up. #EHA2025 $XBI https://t.co/hi73VKtJuZ 1/๐ŸšจWOW @intelliatx presented new data from a 3-year follow-up which showed that a single dose of lonvo-z - $NTLA-2002 led to a 98% ()"
X Link 2025-06-15T18:15Z [----] followers, [----] engagements

"Congrats (kind of) $VERV shareholders So needed for the sector ๐Ÿ‘ Cheap for Eli Lilly"
X Link 2025-06-17T01:41Z [----] followers, [----] engagements

"$BEAM $NTLA $PRME $CRSP should all be up nicely tomorrow Cc - $VERV"
X Link 2025-06-17T01:57Z [----] followers, [----] engagements

"As someone who has been monitoring and critical of the financial status of $PRME I think its a little overdone. They will eventually raise no doubt but they have some heavy hitters including Alphabet (15m shares) BMY (11m shares) and Arch (15m shares) and do not think finding more backers will be challenging. ๐Ÿ‘€ with $GOOG having a strong position. Partnerships / licensing deals also can bring in fresh capital. (L)"
X Link 2025-06-21T22:33Z [----] followers, [----] engagements

"David ADDED again $PRME Not trying to be redundant but this is very bullish in my opinion #blackjack Recent nice inside buying $PRME Nice to see some insiders with a spine . So many stocks are down [--] to 90% in this sector yet insiders have been quiet WEAKNESS Not the case here. Oh yeah the most recent inside buying is from arguably one of the greatest scientist ever. Not https://t.co/TH9e3cj5i3 Recent nice inside buying $PRME Nice to see some insiders with a spine . So many stocks are down [--] to 90% in this sector yet insiders have been quiet WEAKNESS Not the case here. Oh yeah the most"
X Link 2025-06-24T00:47Z [----] followers, [----] engagements

"$IPSC $XBI Background - I have been in talks with AlIs Biosciences regarding century therapeutics. Nick will have a call in the coming weeks with IR. Question assuming you own a nice chunk of shares would you be open to Alis intervening Alis is open to me doing this poll @statnews @adamfeuerstein Yes No Yes No"
X Link 2025-07-22T15:55Z [----] followers, [----] engagements

"$IPSC can confirm that Alis (Nick) will speak with Century Therapeutics tomorrow If cash is [---] post Q2 that is $1.79 / share. $ARKG $XBI"
X Link 2025-07-23T16:42Z [----] followers, [----] engagements

"$IPSC $ARKG $XBI ๐Ÿงต 1/2 I had a wonderful conversation with Nick Johnston (Alis Bioscience founder and board member) this morning regarding Alis Biosciences approach and objectives. Their goal which is also clearly stated on their website is a constructive vs activist approach designed to help the current plethora of small biotech companies which are trading with negative EVs. For context of this problem in early [----] there were nearly [---] companies worldwide with trapped equity totally over $30B (from their website). What surprised me is how user friendly their approach is to both"
X Link 2025-07-27T17:11Z [----] followers, [----] engagements

"2/2 Alis has spoken with IR (Century) and many other institutionsare now aware of Aliss interest in Century Therapeutics. I expect the company to digest Aliss offer to help (no formal proposal has been made) and for communication to occur withshareholders in the coming weeks. Aliss team as one can also imagine has many key contacts with funds and large pharma (i.e. Bayer) which will help streamline their projects. What has been feedback from big pharma The reception to their goal has been how can we help which is very telling. I will state again this approach is not an activist approach"
X Link 2025-07-27T17:12Z [----] followers, [---] engagements

"The leadership at Century Therapeutics/ $IPSC has expressed no interest in engaging with Alis. Regardless of whether it would be in their best interest to consider Aliss intervention Century has made it clear that Alis would not get past investor relations. Its unclear whether Alis will adopt a more aggressive approach or move on given their initially tactful strategy. As a shareholder I find it remarkable that the CEO and at least one prominent board member refused to even entertain a call. I hope Centurys leadership knows what theyre doing as this decision could tarnish their reputations"
X Link 2025-08-05T03:55Z [----] followers, [----] engagements

"$ARWR starting to think a BO would not be in the long term best interests of shareholders. @ArrowheadPharma s valuation wont be able to be held down much longer with their late stage assets and strong early programs. I plan to enjoy the ride"
X Link 2025-08-08T15:11Z [----] followers, [----] engagements

"Incredibly illogical and stupid that marijuana is classified the same as drugs such as heroin $MSOS Will be so ironical if conservatives make this change after years and years of promises from democrats"
X Link 2025-08-10T17:45Z [----] followers, [----] engagements

"Back in $PRME I say this often but plan to just let these sit for the coming years. Worth the risk imo"
X Link 2025-08-12T15:34Z [----] followers, [----] engagements

"$ARWR + $SRPT ๐Ÿ”ฅ Expect doubles in both (not advice)"
X Link 2025-08-13T16:53Z [----] followers, [----] engagements

"$SRPT position now full. Plan / hope is to hold till [--] ish. Always subject to change"
X Link 2025-08-26T21:47Z [----] followers, [----] engagements

"@BikeRieder ๐Ÿ‘ ๐Ÿ’ฅ $ARWR"
X Link 2025-08-30T18:26Z [----] followers, [----] engagements

"$ARWR wonderful news ๐Ÿ‘ @ArrowheadPharma https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-and-novartis-enter-into-a-global-license-and-collaboration-agreement/ https://arrowheadpharma.com/news-press/arrowhead-pharmaceuticals-and-novartis-enter-into-a-global-license-and-collaboration-agreement/"
X Link 2025-09-02T14:13Z [----] followers, [----] engagements

"$IPSC Century Therapeutics Inc. Chardons 9th Annual Genetic Medicines Conference New York NY Was overall very pleased with the call and update. Chad is a partial reason I am still an investor here. Based on this presentation they also may as well change the name of the company to Clade Therapeutics. Chad provided a nice update on the priorities and goals of the company for the upcoming years. CNTY-101 Caramel (Germany) and Calipso-1 progressing and main differences between the trials are that the Caramel trial will only be [--] dose where Calipso-1 will allow re-dosing and with re-dosing the"
X Link 2025-10-22T17:15Z [----] followers, [----] engagements

"Not sure if amended or always existed - Great write up @JessieChimni and I also am a big fan of Chad $IPSC https://bioinformant.com/century-therapeutics-and-fujifilm-cellular-dynamics-announce-licenses/ Finished listening to Chad Cowan CSO $IPSC update at the Chardan conference. I picked up a couple of nuggets: 1) He mentioned that he pioneered the use of +CD47 for allo evasion at $SANA. After doing some research it turns out his lab at Harvard licensed HIP to $SANA. It also https://t.co/yyLO2mlzwZ https://bioinformant.com/century-therapeutics-and-fujifilm-cellular-dynamics-announce-licenses/"
X Link 2025-10-27T15:41Z [----] followers, [----] engagements

"$IPSC From GROK - Century Therapeutics a clinical-stage biotechnology company developing iPSC-derived allogeneic cell therapies for cancer and autoimmune diseases leverages CD300a signaling in its proprietary Allo-Evasion technology to shield its therapeutic payloadengineered T cells NK cells or other iPSC-derived effectorsfrom host immune recognition and destruction. This approach builds directly on CD300as natural role as an inhibitory receptor on innate immune cells like NK cells and macrophages flipping the evasion script: instead of tumors exploiting CD300a to suppress immunity Century"
X Link 2025-11-17T04:05Z [----] followers, [---] engagements

"Here is a summary from AI. Yes Century Therapeutics has full rights to develop manufacture and commercialize iPSC-derived islet cells (specifically beta islets) for type [--] diabetes. On November [--] [----] Century announced its lead program CNTY-813 an iPSC-derived beta islet therapy engineered with their proprietary Allo-Evasion [---] technology for immune evasion (targeting T-cell NK-cell and humoral rejection). This is positioned as an internal wholly-owned program with the goal of durable glycemic control without chronic immunosuppression. Key Evidence of Rights/Ownership The program is fully"
X Link 2025-11-18T06:29Z [----] followers, [--] engagements

"Century Therapeutics $IPSC Piper Sandler 37th Annual Healthcare Conference Fireside Chat Dec [--] 2025) Participants: Brent Pfeiffenberger (CEO) & Chad Cowan (CSO) Key points from the discussion: Allo-Evasion Platform Management expressed high confidence in the current (5.0) edits. First public mention of potential out-licensing of the technology for non-competing fields. I believe the platform has significant standalone value relative to the current $45 M market cap. Type [--] Diabetes Program I was surprised that work for this program actually started in March 2025; remains on track for"
X Link 2025-12-04T07:08Z [----] followers, [----] engagements

"$IPSC great news and wonder if this means Syncona will be going heavy here. Recall Syncona had a very large position in Clade and currently [---] M shares position (Century). https://investors.centurytx.com/news-releases/news-release-details/century-therapeutics-appoints-accomplished-biotechnology-leaders https://investors.centurytx.com/news-releases/news-release-details/century-therapeutics-appoints-accomplished-biotechnology-leaders"
X Link 2025-12-09T15:20Z [----] followers, [----] engagements

"$IPSC Actual MC around 420-450 M and share count = 205M. Excluding warrants. So roughly a 60% discount to $SANA"
X Link 2026-01-16T18:40Z [----] followers, [----] engagements

"@Dadbod4evah Very true. I already had some bereavement time planned for its death lol. These are big guys though and not just a fund taking a stab it seems"
X Link 2026-01-17T03:40Z [----] followers, [---] engagements

"Id assume no reverse stock split I havent seen this meeting cancelled either. Id expect to see a filing tomorrow. $IPSC https://investors.centurytx.com/static-files/7950bb7a-045d-4aab-8968-404509556581 https://investors.centurytx.com/static-files/7950bb7a-045d-4aab-8968-404509556581"
X Link 2026-01-22T06:32Z [----] followers, [---] engagements

"$IPSC very nice recovery from low 1.90s this week. Time to test [---] @steve2bacon @kholov23"
X Link 2026-01-22T16:56Z [----] followers, [---] engagements

"@JessieChimni Night and day how this now trades Really hoping we meet their IND goal this year"
X Link 2026-01-26T21:25Z [----] followers, [---] engagements

"RIP $SLV Closed short for small profit was too early and sick of the volatility ๐Ÿ˜‚"
X Link 2026-01-30T16:45Z [----] followers, [---] engagements

"A boring excellent company $XERS Nice guidance boost"
X Link 2026-01-08T16:36Z [----] followers, [----] engagements

"$CRBU Missed this presentation that was on 4/20/24. Safety is not even comparable and looking at subgroup efficacy should make patients AND investors excited. Huge and comical the current cash on hand to MC ratio. More buying tomorrow. $XBI https://investor.cariboubio.com/static-files/7b62813f-89af-48ae-97bb-4d16a9a82b4f https://investor.cariboubio.com/static-files/7b62813f-89af-48ae-97bb-4d16a9a82b4f"
X Link 2024-04-25T01:28Z [----] followers, 15K engagements

"$SANA Ill choose to be early here and accept the risk of failure. SANA fits in my portfolio as a play that may not work out but has the potential to be a game changer. Nice summary here and contrary to some folks opinion Im a huge fan of Steve Harr. https://www.biospace.com/article/sana-on-track-to-remove-barriers-for-cell-and-gene-therapy-/ https://www.biospace.com/article/sana-on-track-to-remove-barriers-for-cell-and-gene-therapy-/"
X Link 2022-04-24T02:57Z [----] followers, [--] engagements

"Best of luck to all holding through tomorrows decision. $CRSP Also important to appreciate how big of a day it is for patients in need. Science is amazing and progressing at a rapid speed. Medicine likely looks very doffernt in coming decades"
X Link 2023-12-07T23:16Z [----] followers, [----] engagements

"$CRBU the HLA (phenotype) data for CB-010 will be very interesting and could change the allogeneic cell therapy space imo. Hard to believe it wont be strong when Rachel seems to be very excited whenever she discussed it"
X Link 2024-05-28T03:28Z [----] followers, [----] engagements

"RT @yaireinhorn: @collision @dwarkesh_sp @elonmusk WOW - this is huge Cheeky Pint is definitely one of my most favourite podcasts and the"
X Link 2026-02-05T21:09Z [----] followers, [--] engagements

"$SGMO deep pipeline-"
X Link 2021-09-16T04:46Z [----] followers, [--] engagements

"$xbi contrarian opinion. My speculation is we see 300-400 in 3-5 years. Crispr protein degraders and gene editing etc etc hype will max as these treatments completely change medicine. Will be a huge bubble that has some justification"
X Link 2022-02-07T00:34Z [----] followers, [--] engagements

"$CRBU sky was falling around [----] and now everyone is bullish. That was fear I was happy to buy"
X Link 2023-11-15T15:40Z [----] followers, [----] engagements

"$CRBU up 65.4% off lows recently. Winning science execution and leadership"
X Link 2023-11-23T14:38Z [----] followers, [----] engagements

"If you follow me what I post on is my speculative biotech positions 98% of the time. For fun if I consider if I had to hold one or two indefinitely the list would be very short. Likely for me $CRBU makes the list with considerations of many variables. Starts w leadership"
X Link 2024-01-07T19:15Z [----] followers, [----] engagements

"$IPSC $SANA Nice review of innate and adaptive immunity - $SANA and $IPSC - hypoimmune and Allo Evasion respectively try to block payload from immune detection. Have different methodology. Early data looks like both approaches may be effective. https://www.ncbi.nlm.nih.gov/books/NBK279396/ https://www.ncbi.nlm.nih.gov/books/NBK279396/"
X Link 2024-02-18T18:39Z [----] followers, [----] engagements

"Despite concerns w scaleability flyer spec play $ACHL. Trading a serious discount to cash on hand as a little risk buffer *small play until see more data Surprised not up 1000% w AI component https://ir.achillestx.com/static-files/d1f75ff0-b8d4-4b0c-8827-0931e5b91e70 https://ir.achillestx.com/static-files/d1f75ff0-b8d4-4b0c-8827-0931e5b91e70"
X Link 2024-02-23T17:21Z [----] followers, [----] engagements

"1). My notes from $CRBU CEO Dr. Rachel Haurwitz discussion at Leerink * my interpretations not advice and may contain errors"
X Link 2024-03-13T06:00Z [----] followers, 17K engagements

"@JessieChimni I will be massively increasing $SANA position if we reach low threes again"
X Link 2024-08-07T23:49Z [----] followers, [---] engagements

"$CRBU ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ [----] Anticipated milestones CB-010 ANTLER: Caribou plans to present data from both the additional 2L and prior CD19 relapsed LBCL patient cohorts in H1 [----]. Caribou plans to initiate a pivotal Phase [--] clinical trial in H2 [----] should data confirm the initial observation that partial HLA matching drives outcomes that are on par with autologous CAR-T cell therapies. CB-010 GALLOP: Caribou plans to provide updates as the GALLOP Phase [--] clinical trial in LN and ERL advances. CB-011 CaMMouflage: Caribou plans to present dose escalation data from the ongoing CaMMouflage Phase 1"
X Link 2025-01-13T00:42Z [----] followers, [----] engagements

"Myself and Id imagine Casdin Venrock and Bain capital must not be thrilled with @century_tx at all. They all invested much higher yet there is zero C-suite buying at these levels. Company is trading under cash by 140M. The market gives you (-) value and we do not even see a token buy. Hard to ask other investors to believe when leadership isnt seeing value. @BrentPfeiffenb1 $IPSC https://twitter.com/i/web/status/1882867605247295882 https://twitter.com/i/web/status/1882867605247295882"
X Link 2025-01-24T19:06Z [----] followers, [---] engagements

"$IPSC IPSC main institutional holders [--]. Bayer (by proxy) [----] M [--]. Versant (unchanged) [----] M [--]. Fuji (by proxy) [---] M [--]. Bain (unchanged) [---] M [--]. Casdin (increased 61% - [---] M [--]. Venrock (decreased 26%) [---] M [--]. Boxer Capital MANAGEMENT (no change) [---] M [--]. Blackrock (increased 1.58%) [--] M [--]. FMR (increased .49%) [---] M [--]. Vanguard (decreased 3.78%) [---] M [--]. Millennium (increased 1000%) [---] M [--]. Syncona (no change) [---] M [--]. Brent P (CEO small tax planned sale) [---] M Float is [--] M and these [--] holders = [----] M thus about 71% of float. Adage (sold out [---] M) Octagon (sold out 680k)"
X Link 2025-02-26T18:39Z [----] followers, [---] engagements

"Bain capital hasnt sold a single share. Their cost basis is also around $3.70 $IPSC"
X Link 2025-05-15T18:21Z [----] followers, [----] engagements

"Recent nice inside buying $PRME Nice to see some insiders with a spine . So many stocks are down [--] to 90% in this sector yet insiders have been quiet WEAKNESS Not the case here. Oh yeah the most recent inside buying is from arguably one of the greatest scientist ever. Not advice. As someone who has been monitoring and critical of the financial status of $PRME I think its a little overdone. They will eventually raise no doubt but they have some heavy hitters including Alphabet (15m shares) BMY (11m shares) and Arch (15m shares) and do not think https://t.co/qm9xeYPNfh As someone who has been"
X Link 2025-06-22T18:48Z [----] followers, 16.3K engagements

"Biotech $XBI โžก big tech $QQQ #2026 $SPY $ARKG $ARKK"
X Link 2025-12-12T15:28Z [----] followers, [---] engagements

"Excellent article @yaireinhorn $PRME is the future. Squeezing ATM $XBI https://t.co/5QFeB5nkNL https://t.co/5QFeB5nkNL"
X Link 2026-01-22T16:42Z [----] followers, [----] engagements

"$CRSP $XBI $ARKG Wonderful overview of $CRSP and their planned upcoming priorities Love the new format and excellent write up @yaireinhorn ๐Ÿ”ฅ https://t.co/bzmcG6dEtw https://t.co/bzmcG6dEtw"
X Link 2026-01-29T16:33Z [----] followers, [----] engagements

"RT @yaireinhorn: This excellent @CBinsights Infograph of Eli Lillys strategy map is perhaps the best explanation for Eli Lillys phenomena"
X Link 2026-02-05T21:09Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing